pharma · Atherosclerosis · Non-small Cell Lung Cancer (NSCLC)
MSD Merck Sharp
Merck Sharp and Dohme
News and analysis for MSD Merck Sharp on NovaPharmaNews — regulatory, clinical, and market coverage.
WERFTESTRASSE 4, Lucerne, 6005, ch HQ
61 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- WERFTESTRASSE 4, Lucerne, 6005, ch
- Employees
- 61
- Programs
- 217
- Drugs
- 180
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning MSD Merck Sharp — regulatory, clinical, and market coverage.
News and analysis for MSD Merck Sharp on NovaPharmaNews — regulatory, clinical, and market coverage.